Imaging stocks languish again in 1998
Imaging device stocks turned in another poor performance in 1998, according to the results of an industry survey by HealthCare Markets Group (formerly WDI HealthCare Markets Group) of Hilton Head, SC. Shares of companies in the firm's imaging devices
Imaging device stocks turned in another poor performance in 1998, according to the results of an industry survey by HealthCare Markets Group (formerly WDI HealthCare Markets Group) of Hilton Head, SC. Shares of companies in the firm's imaging devices segment fell 23% for the year, placing the segment at 34th out of 39 sectors. Overall, healthcare industry stocks climbed 1.9% for the year.
Imaging's performance last year follows a similarly bleak year in 1997 in the HealthCare Markets Group survey. The imaging devices segment fell 9% for the year, compared with an overall rise of 10% for healthcare stocks in general (SCAN 1/14/98). The imaging devices segment grew 4% in 1996.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
